Neoadjuvant sorafenib combined with gemcitabine plus oxaliplatin in advanced hepatocellular carcinoma

Figure 1 Computed tomography scan. A: A 4.5-cm hypervascular hepatic tumor (arrow) that occupied the sixth hepatic segment, without signs of underlying cirrhosis; B: After eight cycles of gemcitabine and oxaliplatin combined with sorafenib, we observed tumor shrinkage of > 40% (arrow), as compared to baseline assessment; C: Secondary surgery was performed: hemostatic clips were still visible on this postoperative CT scan.